U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR Antibody (IBI37G5)Cat. No. WA1660Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR Antibody (IBI37G5)Cat. No. WA1660
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (TRX518)Cat. No. WA1659
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569)Cat. No. WA1658
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (MK1248)Cat. No. WA1657
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (JNJ-64164711)Cat. No. WA1656
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (GWN323)Cat. No. WA1655
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (FPA154)Cat. No. WA1654
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (EU102)Cat. No. WA1653
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (BMS 986156)Cat. No. WA1652
U-Blot® Research Grade Anti-Human CD357/TNFRSF18/GITR (AMG 228)Cat. No. WA1651
U-Blot® Research Grade Anti-Human CD354/TREM1 (PY159)Cat. No. WA1650
U-Blot® Research Grade Anti-Human CD352/SLAMF6 (SGN-CD352A)Cat. No. WA1649